References
- Committee opinion no. 504. Screening and diagnosis of gestational diabetes mellitus. Obstet Gynecol 2011;118:751–3
- Tutino GE, Tam WH, Yang X, et al. Diabetes and pregnancy: perspectives from Asia. Diab Med 2014;31:302–18
- Carolan M, Davey MA, Biro MA, Kealy M. Maternal age, ethnicity and gestational diabetes mellitus. Midwifery 2012;28:778–83
- Reece EA, Leguizamon G, Wiznitzer A. Gestational diabetes: the need for a common ground. Lancet 2009;373:1789–97
- Vambergue A, Valat AS, Dufour P, et al. Pathophysiology of gestational diabetes. J Gynecol Obstet Reprod Biol 2002;31:4S3–10
- Kumar KG, Trevaskis JL, Lam DD, et al. Identification of adropin as a secreted factor linking dietary macronutrient intake with energy homeostasis and lipid metabolism. Cell Metab 2008;8:468–81
- St-Onge MP, Shechter A, Shlisky J, et al. Fasting plasma adropin concentrations correlate with fat consumption in human females. Obesity 2014;22:1056–63
- Ganesh Kumar K, Zhang J, Gao S, et al. Adropin deficiency is associated with increased adiposity and insulin resistance. Obesity 2012;20:1394–402
- Aydin S, Kuloglu T, Aydin S, et al. Expression of adropin in rat brain, cerebellum, kidneys, heart, liver, and pancreas in streptozotocin-induced diabetes. Mol Cell Biochem 2013;380:73–81
- American Diabetes. A: gestational diabetes mellitus. Diabetes Care 2003;26:S103–5
- Yu HY, Zhao P, Wu MC, et al. Serum adropin levels are decreased in patients with acute myocardial infarction. Regul Peptides 2014;190–191:46–9
- Butler AA, Tam CS, Stanhope KL, et al. Low circulating adropin concentrations with obesity and aging correlate with risk factors for metabolic disease and increase after gastric bypass surgery in humans. J Clin Endocrinol Metab 2012;97:3783–91
- Sayin O, Tokgoz Y, Arslan N. Investigation of adropin and leptin levels in pediatric obesity-related nonalcoholic fatty liver disease. J Pediatr Endocrinol Metab 2014;27:479–84
- Topuz M, Celik A, Aslantas T, et al. Plasma adropin levels predict endothelial dysfunction like flow-mediated dilatation in patients with type 2 diabetes mellitus. J Invest Med 2013;61:1161–4
- Lovren F, Pan Y, Quan A, et al. Adropin is a novel regulator of endothelial function. Circulation 2010;122:S185–92
- Gozal D, Kheirandish-Gozal L, Bhattacharjee R, et al. Circulating adropin concentrations in pediatric obstructive sleep apnea: potential relevance to endothelial function. J Pediatr 2013;163:1122–6
- Aydin S, Kuloglu T, Aydin S, et al. Elevated adropin: a candidate diagnostic marker for myocardial infarction in conjunction with troponin-I. Peptides 2014;58:91–7
- Zhang C, Zhao L, Xu W, et al. Correlation of serum adropin level with coronary artery disease\. Zhonghua yi xue za zhi 2014;94:1255–7
- Wu L, Fang J, Chen L, et al. Low serum adropin is associated with coronary atherosclerosis in type 2 diabetic and non-diabetic patients. Clin Chem Lab Med CCLM/FESCC 2014;52:751–8
- Aydin S, Kuloglu T, Aydin S. Copeptin, adropin and irisin concentrations in breast milk and plasma of healthy women and those with gestational diabetes mellitus. Peptides 2013;47:66–70
- Celik E, Yilmaz E, Celik O, et al. Maternal and fetal adropin levels in gestational diabetes mellitus. J Perinat Med 2013;41:375–80
- Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412–19